tromboosiriskidega
Tromboosiriskidega refers to the presence or consideration of thrombosis risks in medical, pharmacological, or procedural contexts. The term is often used in Estonian healthcare documentation to indicate that a patient or treatment carries an elevated risk of developing a blood clot, whether venous or arterial.
Risk factors associated with tromboosiriskidega include thrombophilia inherited conditions such as factor V Leiden mutation, obesity,
Screening for tromboosiriskidega may involve the use of risk scoring systems such as the Khorana score for
Management of an actual thrombotic event proceeds according to established guidelines and may require anticoagulation, thrombolysis,
Research on tromboosiriskidega continues to refine risk stratification tools and to evaluate novel anticoagulants’ safety profiles.